BIEL (Bioelectronics) Probability of Financial Distress (%)


What is Bioelectronics Probability of Financial Distress (%)?

Bioelectronics does not have enough data to calculate Probability of Financial Distress (%).


Bioelectronics  (OTCPK:BIEL) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.


Bioelectronics Probability of Financial Distress (%) Related Terms


Bioelectronics Probability of Financial Distress (%) Historical Data

* Premium members only.

The historical data trend for Bioelectronics's Probability of Financial Distress (%) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioelectronics Probability of Financial Distress (%) Chart

Bioelectronics Annual Data
Trend
Probability of Financial Distress (%)

Bioelectronics Quarterly Data
Probability of Financial Distress (%)

BIEL vs NUVPF, ADMD, RSPI: Probability of Financial Distress (%) Comparison

For the Medical Devices subindustry, Bioelectronics's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioelectronics Probability of Financial Distress (%) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioelectronics's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where Bioelectronics's Probability of Financial Distress (%) falls into.



Bioelectronics Business Description

Address 3880 Roundtree Road, Suite 1, Jefferson, MD, USA, 21755
Bioelectronics Corp is an electroceutical company. The company develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Its product line includes Actipatch Musculoskeletal Pain Therapy, Allay menstrual pain therapy, Smart insole heel pain therapy, and Recovery RX post operative and Chronic wounds therapy. It sells its products to wholesale distributors, directly to hospitals and clinics, and to consumers. develops & commercializes electrical stimulation/neuromodulation technology. Company products include RecoveryRx, ActiPatch Musculoskeletal Pain Relief, and Others.